Welcome to our dedicated page for TILRAY BRANDS news (Ticker: TLRY), a resource for investors and traders seeking the latest updates and insights on TILRAY BRANDS stock.
Tilray Brands, Inc. operates as a global lifestyle and consumer packaged goods company spanning cannabis, craft beverages, hemp-based foods and wellness products. News about TLRY commonly covers product launches, brand refreshes and retail distribution across beverage and food subsidiaries such as BrewDog, 10 Barrel Brewing, SweetWater Brewing Company, Widmer Brothers Brewing and Manitoba Harvest.
Company updates also address Tilray Medical, international medical cannabis markets, Canadian adult-use and medical cannabis activity, quarterly operating results, acquisitions and capital actions. Recurring coverage links Tilray’s cannabis platform with its beverage and wellness portfolio across North America, Europe and other international markets.
Tilray Brands (NASDAQ: TLRY) urged Congress to adopt a federal hemp framework and a taxed pathway for hemp-derived THC products while rejecting prohibitionist measures in the recent government funding bill dated November 11, 2025. Tilray supports a federal baseline with state flexibility and endorses a 10 mg naturally derived delta-9 THC per serving cap for hemp beverages. The company said hemp-derived THC beverages represent a $1 billion U.S. industry, are not material to Tilray’s revenue or adjusted EBITDA today, and called for collaboration during the bill’s one-year implementation period to protect consumers and support small businesses.
Tilray Medical (NASDAQ: TLRY) announced updates to its Canadian pricing programs on November 4, 2025 to broaden access to medical cannabis for patients, seniors, first responders, pediatric patients, veterans and those facing financial challenges.
The Compassionate Pricing annual income eligibility was increased to CAD 65,000 from CAD 32,500. Applicants must submit a Notice of Assessment for the most recent taxation year to info@tilraymedical.com. Programs continue to include promotional campaigns, Seniors Pricing, First Responders Appreciation, Frontline Workers Appreciation, Pediatric Pricing and Warrior Wellness for Veterans. More details are available at www.tilraymedical.ca.
Tilray Brands (NASDAQ: TLRY) will debut select craft beer brands in Japan at the American Craft Beer Experience Festival in Tokyo’s Hibiya Park from November 22–24, 2025. The company will operate a dedicated booth pouring tap-only selections from 10 Barrel Brewing Co. (Cloud Mentality, Apocalypse IPA), Green Flash Brewing Co. (West Coast IPA) and Alpine Beer Company (Duet IPA).
Tilray said the appearance supports its strategy to expand the beverage business in Asia via the Brewers Association’s Export Development Program, aiming to engage industry leaders, media and consumers and to showcase brewing techniques and flavor profiles.
Redhook Brewing (TLRY) launched Redhook 81 on Oct 23, 2025: a 4.2% ABV light lager with a retro can design aimed at post‑shift relaxation.
Available now in 16oz 12‑packs and 4‑packs where Redhook is sold. A promotional Redhook Grizzly Sweepstakes runs through Nov 30, 2025 at 11:59 p.m. ET, open to legal residents of Idaho, Oregon, and Washington aged 21+, offering a Quittin’ Time Kit and a 4‑pack of Redhook 81.
Tilray Brands (Nasdaq: TLRY) marked seven years since Canada legalized cannabis, reiterating its position as Canada's largest legal cannabis company by revenue and highlighting market-leading brands and product categories. The company cites >C$1 billion invested in Canadian infrastructure, ~C$700 million paid in excise taxes, ownership of 15 leading brands (several retail-valued C$100M–C$300M), and Q1FY26 operational strength.
Tilray reports 5 million sq ft cultivation capacity, current production of 210 metric tons, and >40% beverage market share for XMG/Mollo.
Tilray Medical (NASDAQ: TLRY) announced an expansion into Panama via a joint venture with Top Tech Global Inc., forming Solana Life Group.
Solana Life Group received a medical cannabis license from the National Directorate of Pharmacy and Drugs in Panama authorizing cultivation, manufacturing, import, export, distribution, and sale of medical cannabis. Tilray Medical said it will provide product supply, education, and support to the Panamanian medical community while collaborating with healthcare professionals, regulators, and patient groups to deliver cannabinoid-based therapies.
Tilray Brands (NASDAQ: TLRY) reported record Q1 fiscal 2026 net revenue of $209.5 million, a 5% increase year‑over‑year, and delivered net income of $1.5 million versus a prior‑year loss. Adjusted EBITDA rose 9% to $10.2 million. Cash used in operations improved by $34.0 million to $(1.3) million, while cash on hand strengthened to $264.8 million and net debt was reduced to approximately $4 million. Segment results: cannabis revenue $64.5M (36% gross margin), beverage revenue $55.7M (38% margin), distribution revenue $74.0M (11% margin). Management reiterated fiscal 2026 adjusted EBITDA guidance of $62M–$72M. A live webcast of results was scheduled for Oct 9, 2025.
Tilray (NASDAQ: TLRY) has announced the expansion of its Tilray Craft premium cannabis portfolio in Germany with five new cannabis flower products. These products will be produced at the company's EU-GMP certified facility in Neumünster, Germany as part of the BfArM in-country cultivation program.
The new offerings include various THC concentrations ranging from THC22 to THC30, featuring strains such as Triangle Mints, Platinum Pave 34, and Sunset Sherbet. All products will be available by prescription at German pharmacies, adhering to rigorous quality control standards and protocols to ensure consistency and reliability for patients.
Tilray Brands (NASDAQ:TLRY), a global lifestyle and consumer packaged goods company focused on cannabis, beverage, and wellness industries, has scheduled its first quarter fiscal 2026 earnings release for October 9, 2025. The financial results for the quarter ended August 31, 2025, will be announced before market open.
The company will host a conference call and audio webcast at 8:30 AM Eastern Time on the same day. Shareholders can participate by submitting questions through Robinhood or Say Technologies platforms until October 8, 2025.
Tilray Brands (NASDAQ: TLRY) has unveiled its fall seasonal craft beer lineup featuring Oktoberfest-inspired brews across its portfolio of craft breweries. The collection includes offerings from five distinct breweries: Atwater Brewery's Bloktober Fest (6.1% ABV), Blue Point Brewing's Oktoberfest (5.7% ABV), Breckenridge Brewery's Oktoberfest (6% ABV), Terrapin Beer Company's Oktoberfest (5.5% ABV), and Widmer Brothers' Okto Festive Ale (5.5% ABV).
Led by Chief Growth Officer Prinz Pinakatt, this seasonal release combines traditional German brewing styles with local craft beer innovation, featuring Marzen-style lagers and amber ales designed for fall consumption.